BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29913189)

  • 21. Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance.
    Lacoma A; Molina-Moya B; Prat C; Pimkina E; Diaz J; Dudnyk A; García-Sierra N; Haba L; Maldonado J; Samper S; Ruiz-Manzano J; Ausina V; Dominguez J
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):263-9. PubMed ID: 26256417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
    J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    Rahman SMM; Nasrin R; Rahman A; Ahmed S; Khatun R; Uddin MKM; Rahman MM; Banu S
    PLoS One; 2021; 16(12):e0261329. PubMed ID: 34914803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic predictive values of the Hain genotype MTBDRsl assay in mycobacterial strains isolated from Sudan.
    Adam MAM; Ali HMH; Khalil EAG
    Pan Afr Med J; 2019; 32():124. PubMed ID: 31236189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.
    Feng Y; Liu S; Wang Q; Wang L; Tang S; Wang J; Lu W
    PLoS One; 2013; 8(2):e55292. PubMed ID: 23383320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
    Chikamatsu K; Aono A; Yamada H; Mitarai S
    Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of first-line anti-tuberculosis drug resistance mutations by allele-specific primer extension on a microsphere-based platform.
    Lee SH; Choi HB; Yu SY; Chang UJ; Kim CK; Kim HJ
    Ann Lab Med; 2015 Sep; 35(5):487-93. PubMed ID: 26206684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of tuberculosis genes associated with drug-resistance in paraffin-embedded tissue specimens using next generation sequencing technology].
    Song J; Zhang ZG; Dong YJ; Du WL; Wang YX; Liu ZC; Li K; Zhang Q; Sun Q; Che NY
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):234-241. PubMed ID: 32164095
    [No Abstract]   [Full Text] [Related]  

  • 31. GenoType MTBDRsl performance on clinical samples with diverse genetic background.
    Miotto P; Cabibbe AM; Mantegani P; Borroni E; Fattorini L; Tortoli E; Migliori GB; Cirillo DM
    Eur Respir J; 2012 Sep; 40(3):690-8. PubMed ID: 22267773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.
    Surcouf C; Heng S; Pierre-Audigier C; Cadet-Daniel V; Namouchi A; Murray A; Gicquel B; Guillard B
    BMC Infect Dis; 2011 Sep; 11():255. PubMed ID: 21955640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
    Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
    Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
    Syed RR; Catanzaro DG; Colman RE; Cooney CG; Linger Y; Kukhtin AV; Holmberg RC; Norville R; Crudu V; Ciobanu N; Codreanu A; Seifert M; Hillery N; Chiles P; Catanzaro A; Rodwell TC
    J Clin Microbiol; 2023 Mar; 61(3):e0147822. PubMed ID: 36757183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance.
    Lee YS; Lee BY; Jo KW; Shim TS
    J Infect Chemother; 2017 Dec; 23(12):820-825. PubMed ID: 29066216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the MTBDRsl assay in Georgia.
    Tukvadze N; Bablishvili N; Apsindzelashvili R; Blumberg HM; Kempker RR
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):233-9. PubMed ID: 24429319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
    Pérez-García F; Ruiz-Serrano MJ; López Roa P; Acosta F; Pérez-Lago L; García-De-Viedma D; Bouza E
    J Microbiol Methods; 2017 Aug; 139():74-78. PubMed ID: 28511895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.
    Zeng X; Jing W; Zhang Y; Duan H; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):112-117. PubMed ID: 27345127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.